CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CLOV on Nasdaq
Shares outstanding
416,598,522
Price per share
$2.35
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
135,323,272
Total reported value
$414,041,387
% of total 13F portfolios
0%
Share change
-10,988,558
Value change
-$32,285,796
Number of holders
199
Price from insider filings
$2.35
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.2% $83,180,072 29,813,646 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.8% $67,646,435 24,246,034 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 199 institutional investors reported holding 135,323,272 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV). This represents 32% of the company’s total 416,598,522 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) together control 28% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.3% 30,394,942 -0.01% 0% $93,008,521
VANGUARD GROUP INC 5.5% 23,060,008 -4.9% 0% $70,563,625
GEODE CAPITAL MANAGEMENT, LLC 2.3% 9,720,407 -1.2% 0% $29,748,609
STATE STREET CORP 2.1% 8,951,676 +19% 0% $27,392,129
RENAISSANCE TECHNOLOGIES LLC 1.9% 7,712,700 -27% 0.03% $23,600,862
PNC Financial Services Group, Inc. 1.1% 4,463,811 0% 0.01% $13,659,262
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1% 4,271,515 +9.7% 0% $13,070,836
NORTHERN TRUST CORP 0.81% 3,373,192 -0.08% 0% $10,321,968
Divisadero Street Capital Management, LP 0.66% 2,768,088 0.39% $8,470,349
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.65% 2,701,896 -9.7% 0.01% $8,267,802
UBS Group AG 0.55% 2,282,113 +155% 0% $6,983,266
DIMENSIONAL FUND ADVISORS LP 0.51% 2,140,282 +199% 0% $6,551,257
MORGAN STANLEY 0.48% 2,013,401 -41% 0% $6,161,009
JANE STREET GROUP, LLC 0.47% 1,966,588 +315% 0.01% $6,017,759
CITADEL ADVISORS LLC 0.36% 1,487,650 -58% 0% $4,552,209
Soviero Asset Management, LP 0.34% 1,400,000 +56% 2.6% $4,284,000
GMT CAPITAL CORP 0.31% 1,305,200 0% 0.18% $3,993,912
GROUP ONE TRADING LLC 0.3% 1,237,171 +156% 0.11% $3,785,743
Bank of New York Mellon Corp 0.29% 1,193,626 +1.7% 0% $3,652,495
Invesco Ltd. 0.23% 957,957 -14% 0% $2,931,349
Nuveen, LLC 0.21% 883,536 -2.5% 0% $2,703,620
GOLDMAN SACHS GROUP INC 0.21% 866,410 -63% 0% $2,651,214
IMC-Chicago, LLC 0.21% 859,913 +77% 0.05% $2,631,334
JUPITER ASSET MANAGEMENT LTD 0.2% 850,884 -9.4% 0.02% $2,603,705
Atom Investors LP 0.2% 826,591 0.19% $2,529,368

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 269,528 $665,966 +$13,789 $2.35 12
2025 Q3 135,323,272 $414,041,387 -$32,285,796 $3.06 199
2025 Q2 146,128,655 $407,670,376 +$107,801,104 $2.79 197
2025 Q1 105,851,444 $380,012,727 +$48,891,922 $3.59 197
2024 Q4 92,775,680 $292,290,234 +$33,084,501 $3.15 173
2024 Q3 82,031,282 $231,318,941 +$27,492,527 $2.82 154
2024 Q2 73,223,084 $90,062,636 -$13,953,079 $1.23 121
2024 Q1 89,442,327 $71,016,376 -$5,911,907 $0.79 132
2023 Q4 96,511,448 $91,887,186 +$2,277,396 $0.95 141
2023 Q3 93,620,098 $101,107,320 -$3,078,475 $1.08 138
2023 Q2 96,771,026 $86,789,528 -$22,993,945 $0.90 140
2023 Q1 122,809,816 $103,788,732 -$1,403,557 $0.85 150
2022 Q4 126,098,230 $117,195,358 +$72,200 $0.93 167
2022 Q3 123,383,724 $209,751,673 -$931,167 $1.70 150
2022 Q2 122,450,162 $262,010,857 +$44,394,028 $2.14 156
2022 Q1 99,563,575 $353,476,882 -$114,782,509 $3.55 147
2021 Q4 130,139,458 $484,243,395 +$81,897,100 $3.72 144
2021 Q3 105,648,029 $780,734,717 -$325,418,528 $7.39 131
2021 Q2 141,911,833 $1,889,729,052 -$201,269,843 $13.32 132
2021 Q1 160,035,962 $1,206,298,896 +$1,205,006,987 $7.56 118
2020 Q4 74,874 $1,256,000 +$837,000 $16.76 9
2020 Q3 0 $0 -$113,000 $3.75 0
2020 Q2 $3.75 0
2020 Q1 15,000 $113,000 $7.53 1
2019 Q4 $3.75 0
2019 Q3 $3.75 0
2019 Q2 $3.75 0
2019 Q1 $3.75 0